Liangping Xia
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 28
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 6
- Inflammatory Biomarkers in Disease Prognosis 5
- Cancer-related Molecular Pathways 4
-
- Head and Neck Cancer Studies 9
- Co-authors
- Wenzhuo He (35 shared papers)Chang Jiang (24 shared papers)Xin-Yuan Guan (1 shared paper)Rui‐Hua Xu (1 shared paper)Jiewei Chen (1 shared paper)Xin Chen (1 shared paper)Jiaxing Zhang (1 shared paper)Xiaodan Ma (1 shared paper)
- Journals
- Journal of Cancer (6 papers)Cancer Management and Research (5 papers)BMC Cancer (3 papers)Radiotherapy and Oncology (3 papers)British Journal of Cancer (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Liangping Xia
69 papers receiving 2.0k citations
Liangping Xia's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 586
- Oncology 588
- Immunology 306
- Molecular Biology 945
- Otorhinolaryngology 34
Countries citing papers authored by Liangping Xia
This map shows the geographic impact of Liangping Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangping Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangping Xia more than expected).
Fields of papers citing papers by Liangping Xia
This network shows the impact of papers produced by Liangping Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangping Xia. The network helps show where Liangping Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Liangping Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis Hit paper breakdown → | 2019 | 567 |
| 2 | 2019 | 211 | |
| 3 | 2009 | 144 | |
| 4 | 2018 | 105 | |
| 5 | 2005 | 97 | |
| 6 | 2011 | 90 | |
| 7 | 2019 | 67 | |
| 8 | 2020 | 62 | |
| 9 | 2010 | 50 | |
| 10 | 2008 | 39 | |
| 11 | 2016 | 34 | |
| 12 | 2015 | 33 | |
| 13 | 2023 | 32 | |
| 14 | 2015 | 31 | |
| 15 | 2018 | 29 | |
| 16 | 2022 | 26 | |
| 17 | 2021 | 25 | |
| 18 | 2018 | 23 | |
| 19 | 2020 | 21 | |
| 20 | 2018 | 20 |
About Liangping Xia
Liangping Xia is a scholar working on Oncology, Otorhinolaryngology, Cancer Research, Pathology and Forensic Medicine and Immunology, having authored 71 papers that have together received 2.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Genetic factors in colorectal cancer (5 papers), Cancer-related Molecular Pathways (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Air Quality and Health Impacts (3 papers). The work is most often cited by research in Cancer Research (586 citations), Oncology (588 citations), Immunology (306 citations), Molecular Biology (945 citations) and Otorhinolaryngology (34 citations). Liangping Xia has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wenzhuo He, Chang Jiang, Xin-Yuan Guan, Rui‐Hua Xu, Jiewei Chen, Xin Chen, Jiaxing Zhang, Xiaodan Ma, Olivier Déas and Feng‐Wei Wang. Their work appears in journals such as Journal of Cancer, Cancer Management and Research, BMC Cancer, Radiotherapy and Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.